RecallRadar

FDA Drug recall D-1591-2014

0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306

On 2014-09-24 the FDA classified a Class I recall of 0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306 by Baxter Healthcare, citing presence of Particulate Matter: particulate matter identified as fibers and/or plastics.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1591-2014
ClassificationClass I
Statusterminated
Initiated2014-07-11
Published2014-09-24
Last updated2026-09-13 11:51 UTC
CompanyBaxter Healthcare
DistributionUS

Product

0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

Reason

Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.

Identifiers

ndc0338-0049-01
ndc0338-0049-02
ndc0338-0049-03
ndc0338-0049-04
ndc0338-0049-10
ndc0338-0049-41
ndc0338-0049-11
ndc0338-0049-31
ndc0338-0049-48
ndc0338-0049-18
ndc0338-0049-38
ndc0338-0043-03
ndc0338-0043-04
code_infoLot #: a) P309187, Exp 10/14; b) P298190, Exp 08/14

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1591-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.